People

Dr Arthur Pratt

He is interested in how an improved understanding of the aetiopathogenesis of early rheumatoid arthritis (RA) might improve our ability to diagnose and treat patients with the disease. His research seeks to identify molecular biomarkers that begin to stratify this highly heterogeneous condition into subgroups of clinical significance